• Western blot analysis of lysates from VEC cells, primary antibody was diluted at 1:1000, 4°C over night

Anti-NUDT13 antibody (182-232 aa) (STJ193481)

SKU:
STJ193481

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-NADPH pyrophosphatase NUDT13, mitochondrial (182-232 aa) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: NUDT13
Gene ID: 25961
Uniprot ID: NUD13_HUMAN
Immunogen Region: 182-232 aa
Specificity: This antibody detects endogenous levels of NUD13 at Human/Mouse
Immunogen: Synthesized peptide derived from the human NUD13 at the amino acid range 182-232
Function NAD(P)H pyrophosphatase that hydrolyzes NADH into NMNH and AMP, and NADPH into NMNH and 2',5'-ADP. Has a marked preference for the reduced pyridine nucleotides. Does not show activity toward NAD-capped RNAs.the NAD-cap is an atypical cap present at the 5'-end of some RNAs.
Protein Name Nad(Ph Pyrophosphatase Nudt13 - Mitochondrial
Nucleoside Diphosphate-Linked Moiety X Motif 13
Nudix Motif 13
Protein Kiss-16
Database Links Reactome: R-HSA-499943
Cellular Localisation Mitochondrion
Alternative Antibody Names Anti-Nad(Ph Pyrophosphatase Nudt13 - Mitochondrial antibody
Anti-Nucleoside Diphosphate-Linked Moiety X Motif 13 antibody
Anti-Nudix Motif 13 antibody
Anti-Protein Kiss-16 antibody
Anti-NUDT13 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance